Inhibrx Biosciences Inc. (INBX)

AI Score

Unlock

12.19

0.32 (2.70%)

At close: Apr 23, 2025, 3:59 PM

12.16

-0.21%

After-hours: Apr 23, 2025, 04:17 PM EDT

Inhibrx Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q2 2019	Q1 2019	Q4 2018	Q1 2018	Q4 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Mar 31, 2018	Dec 31, 2017
Cash & Equivalents	152.6M	196.33M	226.86M	252.48M	277.92M	337.33M	192.49M	234.25M	273.87M	146.07M	176.38M	143.47M	131.3M	112.7M	125.73M	107.99M	128.66M	127.67M	5.63M	428K	11.54M	27.63M	6.24M	2.1M	-13.47M	13.47M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	26.94M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	6.83M	6.71M	6.75M	4.59M	3.16M	3.16M	3.16M	3.16M	3.16M	3.16M	3.16M	1.85M	1.85M	245K	245K	245K	245K	245K	771K	295K	245K	3.36M	2.78M	1.73M	-13.47M	n/a
Receivables	420K	455K	1.39M	3.04M	778K	331K	327K	304K	257K	315K	284K	433K	878K	503K	528K	357K	615K	964K	122K	n/a	438K	4.34M	1.78M	690K	n/a	140K
Inventory	n/a	n/a	n/a	n/a	n/a	-331K	10.18M	-304K	-257K	-315K	1.00	5.9M	-878K	5.08M	4.4M	4.38M	-129.28M	-964K	2.75M	n/a	3.21M	1.67M	2.2M	n/a	n/a	n/a
Other Current Assets	816K	10.66M	966K	539K	16.66M	25.97M	324K	9.52M	6.63M	7.68M	609K	600K	7.81M	747K	621K	679K	132.17M	4.18M	296K	2.93M	376K	504K	266K	2.86M	n/a	1.83M
Total Current Assets	160.4M	207.45M	242.06M	274.54M	295.36M	363.3M	203.32M	243.78M	280.49M	153.75M	181.62M	150.4M	139.11M	119.03M	131.28M	113.4M	132.17M	131.85M	8.8M	3.36M	15.56M	34.13M	10.49M	5.66M	13.47M	15.44M
Property-Plant & Equipment	13.54M	8.4M	9.62M	9.45M	9.37M	6.27M	6.68M	6.78M	7.22M	7.93M	8.42M	8.93M	9.49M	9.9M	10.36M	10.86M	11.32M	11.46M	11.73M	11.91M	10.68M	11.23M	10.76M	2.59M	n/a	1.8M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	20.37M	15.12M	16.36M	14.04M	12.53M	9.44M	9.85M	9.94M	10.38M	11.1M	11.59M	10.78M	11.34M	10.15M	10.61M	11.1M	11.57M	11.7M	12.5M	12.21M	10.93M	14.6M	13.54M	4.33M	-13.47M	1.8M
Total Assets	180.77M	222.56M	258.42M	288.58M	307.89M	372.73M	213.17M	253.72M	290.88M	164.85M	193.21M	161.18M	150.45M	129.18M	141.89M	124.5M	143.74M	143.55M	21.3M	15.56M	26.49M	48.73M	24.02M	9.98M	n/a	17.25M
Account Payables	9.24M	12.37M	13.02M	12.37M	10.95M	7.86M	9.7M	10.92M	8.33M	8.57M	9.25M	7.89M	9.13M	12.43M	9.86M	14.29M	13.46M	15.19M	8.91M	9.39M	3.12M	2.75M	3.66M	6.53M	n/a	775K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	-9.87M	119K	149K	166K	440K	717K	1.23M	2.03M	2.77M	3.24M	4.08M	3.08M	5.18M	3.72M	n/a	7.94M	4.18M	4.11M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	2.17M	5.75M	2.06M	2.01M	1.96M	1.91M	1.86M	1.81M	1.76M	1.72M	1.67M	1.63M	1.59M	1.54M	1.5M	9.82M	1.42M	n/a	4.67M	7.67M	9.1M	5.93M	n/a	5.17M
Other Current Liabilities	7.73M	29.89M	17.18M	29.79M	43.3M	35.77M	19.55M	19.67M	17.22M	14.61M	12.47M	9.27M	9.62M	8.33M	6.98M	7.94M	13.36M	2.68M	15.72M	15.85M	4.85M	210K	689K	3.72M	n/a	2.98M
Total Current Liabilities	40.73M	44.09M	39.05M	71.87M	56.31M	35.77M	31.33M	32.64M	27.58M	25.43M	24.2M	20.11M	22.45M	25.15M	21.67M	27.85M	31.4M	32.86M	29.77M	25.24M	20.57M	14.82M	17.56M	16.18M	n/a	8.92M
Long-Term Debt	n/a	n/a	n/a	204.58M	206.97M	205.72M	206.65M	203.26M	202.07M	170.82M	173.93M	113.73M	70.47M	75.54M	75.57M	35.75M	35.95M	11.7M	9.36M	39.74M	37.06M	32.75M	7.54M	3.56M	n/a	9.49M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	1.11M	1.65M	n/a	2.68M	3.17M	3.66M	n/a	n/a	5.14M	180K	180K	180K	180K	7.27M	3K	3.65M	68.12M	60.41M	59.51M	363K	n/a	201K
Total Long-Term Liabilities	6.45M	n/a	n/a	205.14M	208.08M	207.37M	206.65M	205.94M	205.24M	174.48M	173.93M	113.73M	75.61M	75.83M	75.9M	36.06M	36.87M	18.96M	10.77M	43.39M	99.49M	93.16M	67.05M	3.93M	n/a	9.7M
Total Liabilities	47.18M	44.09M	39.05M	277.01M	264.39M	243.14M	237.98M	238.58M	232.82M	199.9M	198.13M	133.83M	98.07M	100.98M	97.57M	63.91M	68.27M	51.83M	40.55M	68.63M	120.06M	107.98M	84.61M	20.11M	n/a	18.61M
Total Debt	8.05M	1.83M	2.17M	210.89M	210.14M	205.72M	208.61M	203.26M	202.07M	172.63M	175.7M	115.45M	70.47M	77.17M	77.15M	37.3M	37.45M	11.7M	10.78M	39.74M	41.73M	40.42M	16.64M	9.49M	n/a	14.66M
Common Stock	1K	1K	1K	5K	5K	5K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	3K	3K	2K	3K	3K	3K	n/a	n/a
Retained Earnings	-106.13M	-58.27M	-14.4M	-692.44M	-613.73M	-520.13M	-468.34M	-421.29M	-372.37M	-331.46M	-296.13M	-258.4M	-227.15M	-205.96M	-185.38M	-164.67M	-145.38M	-127.73M	-109.55M	-89.35M	-69.25M	-32.79M	-21.7M	-17.86M	n/a	-28.77M
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-143.55M	-2.85M	-23.23M	-2.38M	-2.11M	-1.9M	-39.79M	-28.77M	n/a
Shareholders Equity	133.58M	178.47M	219.37M	11.57M	43.5M	129.59M	-24.81M	15.13M	58.06M	-35.05M	-4.92M	27.35M	52.38M	28.2M	44.32M	60.59M	75.47M	91.73M	-19.24M	-53.07M	-93.57M	-59.24M	-60.58M	-10.12M	-1.37M	-28.77M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	26.94M	n/a